Tech Company Financing Transactions

Culmination Bio Funding Round

Amgen Ventures and Merck Global Health Innovation Fund participated in a $10 million funding round for Culmination Bio. The round was announced by the company on 11/29/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

36 South State Street Suite 2200
Salt Lake City, UT 84111
USA

Phone

Undisclosed

Website

www.culmination.com

Email Address

[email protected]

Overview

Provider of biotechnology research services intended to develop novel clinical insights, therapeutic targets, diagnostic opportunities, and care process models. The company helps to generate real-world data that helps to answer complex, compelling questions, enabling researchers to make more informed healthcare decisions.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Lincoln Nadauld

        

Chief Operating Officer

Michael Wiley

        

Browse more venture capital transactions:

Prev: 11/29/2023: Vesper Tool venture capital transaction
Next: 11/29/2023: Rich Data Co. venture capital transaction

Share this article

Where The Data Comes From

We do our best to record every notable VC transaction. VC transactions on this site come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary